Market overview
The global vial market is worth USD 9.7 bn in 2026 and is forecast to reach USD 19.9 bn by 2036, growing at a 7.5% CAGR. United States is the largest country market and Borosilicate glass is the largest by material segment.
| Scope | Small glass and plastic containers of about 2 to 100 millilitres used to pack injectable drugs, vaccines, biologics and diagnostic reagents: borosilicate and soda-lime glass, and cyclic olefin plastic vials. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 9.0 bn |
| Value 2026 | USD 9.7 bn |
| Value 2036 | USD 19.9 bn |
| CAGR 2026-2036 | 7.5% |
| Volume 2026 | 32,090 million units |
| Volume 2036 | 62,920 million units |
| Average price 2026 | USD 0.30 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Vial market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 9.7 bn |
| 2027 | USD 10.4 bn |
| 2028 | USD 11.2 bn |
| 2029 | USD 12.0 bn |
| 2030 | USD 12.9 bn |
| 2031 | USD 13.9 bn |
| 2032 | USD 14.9 bn |
| 2033 | USD 16.1 bn |
| 2034 | USD 17.3 bn |
| 2035 | USD 18.5 bn |
| 2036 | USD 19.9 bn |
Vial market segmentation
By material
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Borosilicate glass | 60.0% | 59.5% | USD 5.8 bn | 7.4% |
| Soda-lime glass | 20.0% | 14.2% | USD 1.9 bn | 3.9% |
| Cyclic olefin plastic | 12.0% | 17.9% | USD 1.2 bn | 11.9% |
| Other plastics | 8.0% | 8.3% | USD 774 mn | 7.9% |
By end use
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Biologics and vaccines | 38.0% | 47.3% | USD 3.7 bn | 9.9% |
| Generic and small-molecule drugs | 30.0% | 24.6% | USD 2.9 bn | 5.4% |
| Diagnostics and laboratory | 14.0% | 12.6% | USD 1.4 bn | 6.4% |
| Other uses | 18.0% | 15.5% | USD 1.7 bn | 5.9% |
By volume
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Micro vials | 34.0% | 30.0% | USD 3.3 bn | 6.2% |
| Standard vials | 38.0% | 38.0% | USD 3.7 bn | 7.5% |
| Large vials | 20.0% | 22.0% | USD 1.9 bn | 8.5% |
| Bulk vials | 8.0% | 10.0% | USD 774 mn | 9.9% |
By closure
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Crimp | 48.0% | 44.0% | USD 4.6 bn | 6.6% |
| Screw cap | 30.0% | 30.0% | USD 2.9 bn | 7.5% |
| Flip-off and other | 22.0% | 26.0% | USD 2.1 bn | 9.3% |
By type
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Standard bulk | 40.0% | 34.0% | USD 3.9 bn | 5.8% |
| Ready-to-use sterile | 34.0% | 40.0% | USD 3.3 bn | 9.3% |
| Pre-filled and nested | 26.0% | 26.0% | USD 2.5 bn | 7.5% |
Top 25 countries for vial by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 77.5% of 2026 revenue and the 25 countries below together hold 93.2%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 2.3 bn | 24.0% | USD 4.7 bn | 7.3% |
| 2 | China | USD 1.5 bn | 15.0% | USD 3.4 bn | 8.8% |
| 3 | Germany | USD 774 mn | 8.0% | USD 1.4 bn | 6.2% |
| 4 | India | USD 774 mn | 8.0% | USD 2.0 bn | 9.8% |
| 5 | Japan | USD 484 mn | 5.0% | USD 857 mn | 5.9% |
| 6 | Italy | USD 387 mn | 4.0% | USD 718 mn | 6.4% |
| 7 | France | USD 387 mn | 4.0% | USD 718 mn | 6.4% |
| 8 | United Kingdom | USD 339 mn | 3.5% | USD 618 mn | 6.2% |
| 9 | Switzerland | USD 290 mn | 3.0% | USD 558 mn | 6.8% |
| 10 | Brazil | USD 290 mn | 3.0% | USD 618 mn | 7.8% |
| 11 | Mexico | USD 282 mn | 2.9% | USD 580 mn | 7.5% |
| 12 | Spain | USD 211 mn | 2.2% | USD 385 mn | 6.2% |
| 13 | Canada | USD 156 mn | 1.6% | USD 283 mn | 6.2% |
| 14 | Russia | USD 126 mn | 1.3% | USD 229 mn | 6.2% |
| 15 | Poland | USD 106 mn | 1.1% | USD 275 mn | 10.0% |
| 16 | Turkey | USD 93 mn | 1.0% | USD 239 mn | 9.9% |
| 17 | Netherlands | USD 82 mn | 0.8% | USD 150 mn | 6.2% |
| 18 | Indonesia | USD 74 mn | 0.8% | USD 193 mn | 10.0% |
| 19 | Australia | USD 69 mn | 0.7% | USD 124 mn | 6.0% |
| 20 | Belgium | USD 63 mn | 0.7% | USD 116 mn | 6.3% |
| 21 | Thailand | USD 59 mn | 0.6% | USD 152 mn | 9.9% |
| 22 | South Korea | USD 55 mn | 0.6% | USD 100 mn | 6.1% |
| 23 | Argentina | USD 52 mn | 0.5% | USD 134 mn | 9.8% |
| 24 | Saudi Arabia | USD 49 mn | 0.5% | USD 128 mn | 10.0% |
| 25 | Taiwan | USD 46 mn | 0.5% | USD 86 mn | 6.3% |
| Rest of world | USD 653 mn | 6.8% | USD 1.2 bn | 6.4% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- SCHOTT Pharma
- Gerresheimer
- Stevanato Group
- Corning
- Nipro
- West Pharmaceutical Services
Group 2: Regional and specialist players
- SGD Pharma
- Bormioli Pharma
- Shandong Pharmaceutical Glass
- Neubor Glass
- DWK Life Sciences
- Linuo Group
- Sisecam
Group 3: Emerging and niche players
- Borosil
- Kapoor Glass
- Haldyn Glass
- Cangzhou Four-Star Glass
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the vial market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 7.5% is calculated from the resulting values.
The market is divided by material, by end use, by volume, by closure, by type. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the vial market?
The global vial market is estimated at USD 9.0 bn in 2025 and USD 9.7 bn in 2026.
How fast will the vial market grow?
It is forecast to reach USD 19.9 bn by 2036, a compound annual growth rate of 7.5% from 2026, an increase of USD 10.3 bn.
Which country is the largest market for vial?
United States is the largest market by revenue at USD 2.3 bn in 2026, 24.0% of the global total. The three largest countries together hold 47.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 9.8% a year from 2026 to 2036.
Which vial segment is largest?
In the by material split, Borosilicate glass is the largest segment with 60.0% of 2026 revenue.
Who are the leading vial companies?
Global leaders include SCHOTT Pharma, Gerresheimer, Stevanato Group, Corning.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Softgel CapsuleUSD 9.6 bn · 6.6% CAGR
- Cell TherapyUSD 9.4 bn · 20.0% CAGR
- Lateral Flow AssayUSD 10.0 bn · 5.0% CAGR
- Protein PurificationUSD 9.3 bn · 9.0% CAGR
- Pharmaceutical ExcipientsUSD 10.1 bn · 6.5% CAGR
- FermentationUSD 10.3 bn · 8.5% CAGR
- Filtration MembraneUSD 10.3 bn · 8.5% CAGR
- Pharmaceutical LabelingUSD 9.0 bn · 5.8% CAGR